Form 4: Tango Therapeutics CFO Daniella Beckman Reports Stock and Option Transactions
SEC Form 4 Filing
Daniella Beckman, CFO of Tango Therapeutics, reports acquisition of restricted stock units and stock options, along with disposition of common stock.
Summary
- On February 3, 2025, Daniella Beckman, the Chief Financial Officer of Tango Therapeutics, reported transactions involving the company's securities.
- Beckman acquired 26,119 restricted stock units (RSUs) and disposed of 158,516 shares of common stock.
- She also acquired options to purchase 156,713 shares of common stock at an exercise price of $2.91, exercisable beginning January 1, 2026.
- The RSUs vest over a three-year period, and the stock options vest over a four-year period.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing related to insider transactions. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.
Industry Context
Form 4 filings are a routine part of compliance for company insiders and provide transparency into their transactions in the company's securities. This filing is standard practice and doesn't necessarily indicate a significant shift in the company's prospects.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the transactions of a key executive.
Key Dates
| Date | Description |
|---|---|
| 02/03/2025 | Date of transactions: acquisition of RSUs and stock options, disposition of common stock |
| 02/05/2025 | Date of signature on the Form 4 filing |
| 01/01/2026 | First vesting date for stock options (25%) |
| 02/02/2026 | First vesting date for RSUs (33%) |
| 02/01/2027 | Second vesting date for RSUs (33%) |
| 02/14/2028 | Final vesting date for RSUs (34%) |
| 02/03/2035 | Expiration date for stock options |
Keywords
Tango Therapeutics, TNGX, Form 4, Beneficial Ownership, Daniella Beckman, CFO, Restricted Stock Units, Stock Options, Securities Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.